Livry Gargan, France

Philippe Mackiewicz


Average Co-Inventor Count = 3.0

ph-index = 4

Forward Citations = 90(Granted Patents)


Company Filing History:


Years Active: 1994-2000

Loading Chart...
9 patents (USPTO):Explore Patents

Title: Philippe Mackiewicz: Innovator in Pharmaceutical Chemistry

Introduction

Philippe Mackiewicz is a notable inventor based in Livry Gargan, France. He has made significant contributions to the field of pharmaceutical chemistry, holding a total of nine patents. His work has focused on the preparation processes of various chemical compounds, particularly in the realm of steroid synthesis.

Latest Patents

Among his latest patents is a process for the preparation of phenylimidazolidine. Additionally, he has developed intermediates for the preparation of 6.alpha., 9.alpha.-difluoro steroids. One of his notable compounds is characterized by a specific formula where R can be hydrogen or an ester remainder, X can be hydrogen or fluorine, and Y represents various configurations. These innovations reflect his expertise in complex chemical synthesis.

Career Highlights

Philippe Mackiewicz has worked with prominent companies in the pharmaceutical industry, including Roussel Uclaf and Hoechst Marion Roussel. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in drug development.

Collaborations

Throughout his career, Philippe has collaborated with esteemed colleagues such as Jean-Yves Godard and Christian Richard. These partnerships have fostered a collaborative environment that has led to innovative solutions in pharmaceutical research.

Conclusion

Philippe Mackiewicz's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as a key innovator in the field. His work continues to influence the development of new therapeutic compounds.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…